Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gif. Ch Regulatory News (BGCG)

Share Price Information for Baillie Gif. Ch (BGCG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 198.00
Bid: 195.00
Ask: 197.00
Change: 2.00 (1.02%)
Spread: 2.00 (1.026%)
Open: 198.50
High: 200.00
Low: 195.00
Prev. Close: 196.00
BGCG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Jun 2021 15:26

RNS Number : 1460C
Baillie Gifford China Grwth TrstPLC
16 June 2021
 

Baillie Gifford China Growth Trust plc (BGCG)

Legal Entity Identifier: 213800KOK5G3XYI7ZX18

Appointment of Director

 

 

The Board is pleased to announce the appointment of Mr Tim Clissold as a non-executive Director of the Company with effect from 1 October 2021.

 

Tim qualified as a Chartered Accountant and has worked in Australia, Hong Kong and extensively in China, where he was co-founder of one of the first private equity groups in the country. He later ran Goldman Sachs China's distressed investment business in Beijing. He co-founded another business to originate UN carbon offsets from GHG emission reduction projects in China. Tim is Chief Resolution Officer at Peony Advisors Limited, a company which helps foreign investors recover value after being disenfranchised by Chinese companies and is a non-executive director of Henderson Far East Income Limited. He was a member of the Strategic Advisory Board of Braemar Energy Ventures, a New York venture capital fund focused on energy efficiency technologies. He is the author of Mr China and Chinese Rules and speaks, reads and writes Mandarin Chinese.

 

Susan Platts-Martin, Chair of Baillie Gifford China Growth Trust, commented:

 

"My fellow Directors and I are delighted to welcome Tim to the Board. Tim brings to the Board a wealth of experience relating to China having lived and done business there for many years."

 

Mr Clissold has a beneficial interest of 10,000 shares in the Company.

 

The appointment of Mr Tim Clissold falls to be ratified by shareholders at the Annual General Meeting of the Company to be held in 2022.

 

There is no information required to be disclosed under section 9.6.13 of the Listing Rules.

 

 

 

Baillie Gifford & Co Limited

Managers and Secretaries

16 June 2021

 

Regulated Information Classification: Additional regulated information required to be disclosed under relevant laws.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUAPQUPGGCQ
Date   Source Headline
26th Jan 202411:49 amRNSNet Asset Value(s)
25th Jan 20241:24 pmRNSNet Asset Value(s)
24th Jan 202412:59 pmRNSNet Asset Value(s)
23rd Jan 202411:37 amRNSNet Asset Value(s)
22nd Jan 202411:25 amRNSNet Asset Value(s)
19th Jan 202411:53 amRNSNet Asset Value(s)
18th Jan 20244:54 pmRNSTransaction in Own Shares
18th Jan 202412:25 pmRNSNet Asset Value(s)
17th Jan 20244:50 pmRNSTransaction in Own Shares
17th Jan 202411:41 amRNSNet Asset Value(s)
16th Jan 20244:52 pmRNSTransaction in Own Shares
16th Jan 202411:35 amRNSNet Asset Value(s)
15th Jan 20244:17 pmRNSTransaction in Own Shares
15th Jan 202411:06 amRNSNet Asset Value(s)
12th Jan 202412:03 pmRNSNet Asset Value(s)
11th Jan 20244:55 pmRNSTransaction in Own Shares
11th Jan 202411:02 amRNSNet Asset Value(s)
10th Jan 20242:35 pmRNSNet Asset Value(s)
9th Jan 20244:59 pmRNSTransaction in Own Shares
9th Jan 202411:08 amRNSNet Asset Value(s)
8th Jan 202411:00 amRNSNet Asset Value(s)
5th Jan 202410:58 amRNSNet Asset Value(s)
4th Jan 202411:07 amRNSNet Asset Value(s)
3rd Jan 202410:57 amRNSNet Asset Value(s)
2nd Jan 20243:39 pmRNSNet Asset Value(s)
29th Dec 202311:10 amRNSNet Asset Value(s)
28th Dec 202310:56 amRNSNet Asset Value(s)
27th Dec 202312:41 pmRNSNet Asset Value(s)
27th Dec 202311:49 amRNSNet Asset Value(s)
27th Dec 202310:56 amRNSNet Asset Value(s)
22nd Dec 202310:56 amRNSNet Asset Value(s)
21st Dec 202312:41 pmRNSNet Asset Value(s)
20th Dec 202311:57 amRNSNet Asset Value(s)
19th Dec 202311:51 amRNSNet Asset Value(s)
18th Dec 202312:20 pmRNSNet Asset Value(s)
15th Dec 202311:31 amRNSNet Asset Value(s)
14th Dec 202311:21 amRNSNet Asset Value(s)
13th Dec 202310:59 amRNSNet Asset Value(s)
12th Dec 202311:29 amRNSNet Asset Value(s)
12th Dec 20239:21 amEQSEdison issues update on Baillie Gifford China Growth Trust (BGCG): China’s recovery well worth the wait
11th Dec 202310:58 amRNSNet Asset Value(s)
8th Dec 202311:40 amRNSNet Asset Value(s)
7th Dec 202311:40 amRNSNet Asset Value(s)
6th Dec 202311:05 amRNSNet Asset Value(s)
5th Dec 202311:06 amRNSNet Asset Value(s)
4th Dec 202311:13 amRNSNet Asset Value(s)
1st Dec 202312:04 pmRNSNet Asset Value(s)
30th Nov 202312:20 pmRNSNet Asset Value(s)
29th Nov 202311:17 amRNSNet Asset Value(s)
28th Nov 202310:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.